Among 260 Wayuu, Eñepa and Warao women who took their own samples, 55.4% carried HPV; the nonavalent vaccine covered a type in 69.4% of infected women, and cytology and HPV testing agreed poorly.
Published as "Divergent Human Papillomavirus Genotype Spectra in Three Indigenous Communities of Venezuela: Implications for Vaccine Choice and Cervical Screening". Researchers at the Universidad Central de Venezuela tested self-collected samples from women in La Guajira (Wayuu), Maniapure (Eñepa) and Delta Amacuro (Warao) with a PCR assay resolving 21 genotypes; cytology was available for 144.
The authors state that HPV vaccination is not part of the Venezuelan national programme, and read their data as favouring the nonavalent vaccine and HPV-based screening with a workable triage step.
Shares Ministerio del Poder Popular para la Salud (Venezuela), HPV & HBV vaccination, Cervical cancer.
Shares Ministerio del Poder Popular para la Salud (Venezuela), Cervical cancer.
Shares Ministerio del Poder Popular para la Salud (Venezuela), Cervical cancer.
Shares Ministerio del Poder Popular para la Salud (Venezuela), Cervical cancer.
Shares Ministerio del Poder Popular para la Salud (Venezuela), Cervical cancer.
Shares Ministerio del Poder Popular para la Salud (Venezuela), Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Shares HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/